Fundraising FoxAdjuvant Capital — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
InDevR develops off-the-shelf and custom analytical testing solutions, including its VaxArray microarray platform and multiplex immunoassays, for the development, optimization, and manufacturing of mRNA-, protein-, polysaccharide, conjugate, and viral vector-based vaccines.
BiotechHardwareHealthtechMedical DevicesBoulder, US
Kathy Rowlen(Co-founder, Scientific Advisor (former CEO))inShannon Rodriguez(Chief Operations Officer)inErica Dawson(Chief Technical Officer)inCraig Hoechstetter(Chief Commercial Officer)inMichael Chang(Director)Laura Kuck(Executive Officer)
Themis offers lending backed by non-fungible tokens, allowing holders to deposit an NFT as collateral and borrow against it.
Neepa Patel(Founder)in
Co-investorsGhaf Capital PartnersLD CapitalNFXFelicis VenturesGlobal Health Investment FundHadean Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.